GIONCO DAVID (Chief Accounting Officer) received a stock award from STEMLINE THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/10/2020ACC: 0001104659-20-071841
Officer· Chief Accounting Officer
Since Feb 2019
-327.98K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
45K acquired · 372.98K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+45K
Price / share
—
Trade value
—
% of position
15.9%
6/10/2020
282.88K→327.88K
Common Stock
Direct
Shares
−327.88K
Price / share
—
Trade value
—
% of position
New position
6/10/2020
327.88K→0.00
Total
Net shares
−282.88K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/10/2020 | A · Award | +45K | — | — | 15.9% | 282.88K | 327.88K |
| Common Stock Direct | 6/10/2020 | U · U | −327.88K | — | — | New position | 327.88K | 0.00 |
| Total | −282.88K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
45.10K shares
Shares
−45.10K
Strike price
4.12
Held after
0.00
Exercisable
—
6/10/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock45.10K shares | 6/10/2020 | D · Disposition | −45.10K | 4.12 | — | 0.00 |